These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 6085294)
1. [In vitro changes in natural killer cell activity in draining lymph nodes of oral carcinomas]. Vinzenz K; Strassl H; Micksche M Dtsch Z Mund Kiefer Gesichtschir; 1984; 8(6):421-7. PubMed ID: 6085294 [No Abstract] [Full Text] [Related]
2. Natural cytotoxicity in draining lymph nodes of squamous cell cancer in the maxillofacial region. Vinzenz K; Micksche M J Oral Maxillofac Surg; 1987 Jan; 45(1):42-7. PubMed ID: 2432206 [TBL] [Abstract][Full Text] [Related]
3. Natural killer cell activity in the perigastric lymph nodes from patients with gastric carcinoma or benign lesions. Koba F; Akiyoshi T; Tsuji H J Clin Lab Immunol; 1987 Aug; 23(4):191-5. PubMed ID: 2959787 [TBL] [Abstract][Full Text] [Related]
4. Natural killer cell activity in oral cancer patients. I. Correlation with tumor size and metastasis in regional lymph nodes. Jamkar AV; Gore MM; Kedarnath N; Banerjea AC; Mehta MJ; Ghosh SN Indian J Cancer; 1983 Mar; 20(1A):49-53. PubMed ID: 6873992 [No Abstract] [Full Text] [Related]
5. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells. Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523 [TBL] [Abstract][Full Text] [Related]
6. Infiltration of dendritic cells and NK cells into the sentinel lymph node in oral cavity cancer. Sakakura K; Chikamatsu K; Sakurai T; Takahashi K; Murata T; Oriuchi N; Furuya N Oral Oncol; 2005 Jan; 41(1):89-96. PubMed ID: 15598591 [TBL] [Abstract][Full Text] [Related]
7. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease. Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405 [TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity in oral cancer patients: II. Correlation of in-vitro modulation by leukocyte interferon with circulating interferon and interferon induction by K 562 cells. Gore MM; Jamkar AV; Kedarnath N; Banerjea AC; Mehta MJ; Ghosh SN Indian J Cancer; 1983 Mar; 20(1A):54-8. PubMed ID: 6873993 [No Abstract] [Full Text] [Related]
9. A high concentration of MMP-2/gelatinase A and MMP-9/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line. Lee BK; Kim MJ; Jang HS; Lee HR; Ahn KM; Lee JH; Choung PH; Kim MJ In Vivo; 2008; 22(5):593-7. PubMed ID: 18853752 [TBL] [Abstract][Full Text] [Related]
10. [The significance of the lymphoid stromal reaction in the appearance of neck metastases in T1 and T2 carcinoma of the oral cavity]. Matulić Z; Dujella J; Virag M Chir Maxillofac Plast; 1982; 12(2-3):59-66. PubMed ID: 6964144 [No Abstract] [Full Text] [Related]
11. In vitro interactions of purified cloned human interferons on NK cells: enhanced activation. Targan S; Stebbing N J Immunol; 1982 Sep; 129(3):934-5. PubMed ID: 6180004 [No Abstract] [Full Text] [Related]
12. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity. Lutz CT; Kurago ZB Cancer Res; 1999 Nov; 59(22):5793-9. PubMed ID: 10582701 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes. Lee SH; Kelley S; Chiu H; Stebbing N Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222 [TBL] [Abstract][Full Text] [Related]
14. Natural cytotoxicity in the guinea-pig: the natural killer (NK) cell activity of the Kurloff cell. Eremin O; Coombs RR; Ashby J; Plumb D Immunology; 1980 Oct; 41(2):367-78. PubMed ID: 7439932 [TBL] [Abstract][Full Text] [Related]
15. Natural killer cells in lymph nodes of healthy calves express CD16 and show both cytotoxic and cytokine-producing properties. Boysen P; Gunnes G; Pende D; Valheim M; Storset AK Dev Comp Immunol; 2008; 32(7):773-83. PubMed ID: 18177938 [TBL] [Abstract][Full Text] [Related]
16. Systemic and regional natural cytotoxicity in patients with head and neck cancer. Vinzenz K; Micksche M J Maxillofac Surg; 1986 Oct; 14(5):270-5. PubMed ID: 3464682 [TBL] [Abstract][Full Text] [Related]
17. Murine lymph node natural killer cells: regulatory mechanisms of activation or suppression. Hisano G; Hanna N J Natl Cancer Inst; 1982 Sep; 69(3):665-71. PubMed ID: 6180211 [TBL] [Abstract][Full Text] [Related]
18. Deficient natural killer cell function in preeclampsia. Alanen A; Lassila O Obstet Gynecol; 1982 Nov; 60(5):631-4. PubMed ID: 6183628 [TBL] [Abstract][Full Text] [Related]
19. Distribution of natural killer cell activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro treatment with interferon preparation. Antonelli P; Stewart W; Dupont B Clin Immunol Immunopathol; 1981 May; 19(2):161-9. PubMed ID: 6164514 [No Abstract] [Full Text] [Related]
20. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor. van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]